Patents Assigned to Prothena Therapeutics Limited
  • TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
    Publication number: 20180360934
    Abstract: Methods useful for effecting prophylaxis or treatment of amyloidosis, including AA Amyloidosis and AL amyloidosis, by administering peptides comprising neoepitopes, such as AA fragments from a C-terminal region of AA, and antibodies specific for neoepitopes of aggregated amyloid proteins, for example, antibodies specific for the C-terminal region of AA fibrils. Antibodies for inhibition of formation and/or increasing clearance of amyloid deposits in a patient thus effecting prophylaxis or treating amyloid disease.
    Type: Application
    Filed: May 29, 2018
    Publication date: December 20, 2018
    Applicants: PROTHENA THERAPEUTICS LIMITED, UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: DALE B. SCHENK, PETER A. SEUBERT, JONATHAN WALL, JOSÉ SALDANHA
  • ANTIBODY FORMULATIONS AND METHODS
    Publication number: 20180235887
    Abstract: Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.
    Type: Application
    Filed: January 11, 2018
    Publication date: August 23, 2018
    Applicant: PROTHENA THERAPEUTICS LIMITED
    Inventors: Patrick GARIDEL, Isaac Craig HENDERSON, Pamela KLEIN
  • Antibody formulations and methods for treating AL amyloidosis
    Patent number: 9884020
    Abstract: Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.
    Type: Grant
    Filed: April 27, 2016
    Date of Patent: February 6, 2018
    Assignee: PROTHENA THERAPEUTICS LIMITED
    Inventors: Patrick Garidel, Isaac Craig Henderson, Pamela Klein
  • TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS
    Publication number: 20170081396
    Abstract: Methods useful for effecting prophylaxis or treatment of amyloidosis, including AA Amyloidosis and AL amyloidosis, by administering peptides comprising neoepitopes, such as AA fragments from a C-terminal region of AA, and antibodies specific for neoepitopes of aggregated amyloid proteins, for example, antibodies specific for the C-terminal region of AA fibrils. Antibodies for inhibition of formation and/or increasing clearance of amyloid deposits in a patient thus effecting prophylaxis or treating amyloid disease.
    Type: Application
    Filed: May 20, 2016
    Publication date: March 23, 2017
    Applicants: PROTHENA THERAPEUTICS LIMITED, UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
    Inventors: DALE B. SCHENK, PETER A. SEUBERT, JONATHAN WALL, JOSÉ SALDANHA
  • ANTIBODY FORMULATIONS AND METHODS
    Publication number: 20160310430
    Abstract: Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.
    Type: Application
    Filed: April 27, 2016
    Publication date: October 27, 2016
    Applicant: PROTHENA THERAPEUTICS LIMITED
    Inventors: Patrick GARIDEL, Isaac Craig HENDERSON, Pamela KLEIN
  • ANTIBODY FORMULATIONS AND METHODS
    Publication number: 20150344555
    Abstract: Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.
    Type: Application
    Filed: May 22, 2015
    Publication date: December 3, 2015
    Applicant: PROTHENA THERAPEUTICS LIMITED
    Inventors: Patrick GARIDEL, Isaac Craig HENDERSON, Pamela KLEIN
  • Antibody formulations and methods
    Patent number: 9089529
    Abstract: Antibody formulations and methods useful for prophylaxis or treatment of amyloidosis, including AA amyloidosis and AL amyloidosis.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: July 28, 2015
    Assignee: Prothena Therapeutics Limited
    Inventors: Patrick Garidel, Isaac Craig Henderson, Pamela Klein